Authors reply: An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples

University Federico II of Napoli, Department of Medical Oncology, Endocrinology and Oncology , Naples , Italy.
Expert Opinion on Pharmacotherapy (Impact Factor: 3.53). 03/2012; 13(7). DOI: 10.1517/14656566.2012.668097
Source: PubMed
1 Follower
7 Reads